Daily Health
·06/04/2026
As we age, our brains undergo changes, particularly in the hippocampus—the hub for learning and memory. This can lead to cognitive decline. However, recent research from scientists at UC San Francisco offers a new perspective on this process, pinpointing a single protein that appears to be a major driver of brain aging and, excitingly, a potential target for reversing it.
In a study published in Nature Aging, researchers meticulously tracked genetic and protein changes in the hippocampus of aging mice. One protein, FTL1, consistently stood out. Its levels were significantly higher in older mice, which also exhibited fewer connections between their neurons and performed worse on memory tests.
To confirm the link, the team artificially increased FTL1 levels in young, healthy mice. The results were striking: the young mice's brains began to look and function like those of much older animals. Lab experiments further revealed that nerve cells producing high amounts of FTL1 developed simplified structures, losing the complex, branching networks essential for robust communication. This suggests that an overabundance of FTL1 may contribute directly to the structural and functional decline seen in the aging brain.
The most groundbreaking part of the study came when scientists reduced FTL1 levels in older mice. The animals showed remarkable signs of recovery. The connections between their brain cells multiplied, and their performance on memory tests improved significantly. Saul Villeda, the study's senior author, described it as "truly a reversal of impairments," not just a delay of symptoms.
Further investigation uncovered a connection between FTL1 and cellular metabolism. Higher levels of the protein seemed to slow down how brain cells in the hippocampus use energy. When researchers treated these cells with a compound designed to boost metabolism, the negative effects of FTL1 were prevented. These findings open a promising new avenue for developing treatments that could one day target FTL1 to counteract its effects, potentially alleviating some of the most challenging consequences of brain aging in humans.









